ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.025,75
-0,58%
S&P 500
5.105,60
-0,21%
Dow Jones
38.197,39
-0,49%
Euro vs US Dollar
1,07056
-0,09%
Bitcoin
60.715,00
-4,89%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Vertex Pharmaceuticals Inc (VRTX)

  7. Vertex Pharmaceuticals Inc (VRTX) News

VRTX Vertex Pharmaceuticals Inc

394,56
-1,64 (-0,41%)
Zuletzt aktualisiert: 15:56:15
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Vertex Pharmaceuticals Inc VRTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-1,64 -0,41% 394,56 15:56:15
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
396,20 392,50 396,20 396,20
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
26.4.202417:43BWVertex Announces European Commission Approval for KALYDECO®..
23.4.202406:45PRNCAVERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING..
18.4.202414:00BWVertex Announces Advancements of Suzetrigine (VX-548) in..
11.4.202413:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
10.4.202422:01BWVertex Enters Into Agreement to Acquire Alpine Immune..
09.4.202422:05BWVertex to Announce First Quarter 2024 Financial Results on..
01.4.202417:00PRNCAVertex annonce que la présentation de drogue nouvelle..
01.4.202414:00BWVertex Advances Inaxaplin (VX-147) into Phase 3 Portion of..
21.3.202413:00BWVertex Announces FDA Clearance of Investigational New Drug..
27.2.202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202419:19EDGAR2Form 144 - Report of proposed sale of securities
26.2.202417:25EDGAR2Form 144 - Report of proposed sale of securities
26.2.202417:10EDGAR2Form 144 - Report of proposed sale of securities
26.2.202416:52EDGAR2Form 144 - Report of proposed sale of securities
26.2.202416:44EDGAR2Form 144 - Report of proposed sale of securities
26.2.202416:26EDGAR2Form 144 - Report of proposed sale of securities
23.2.202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202413:10BWVertex Receives CHMP Positive Opinion for KALYDECO® for the..
21.2.202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202417:38EDGAR2Form 144 - Report of proposed sale of securities
21.2.202416:52EDGAR2Form 144 - Report of proposed sale of securities
21.2.202416:44EDGAR2Form 144 - Report of proposed sale of securities
21.2.202416:16EDGAR2Form 144 - Report of proposed sale of securities
21.2.202415:50EDGAR2Form 144 - Report of proposed sale of securities
21.2.202415:43EDGAR2Form 144 - Report of proposed sale of securities
20.2.202422:05BWVertex to Participate in Upcoming Investor Conferences
20.2.202417:29EDGAR2Form 144 - Report of proposed sale of securities
20.2.202417:03EDGAR2Form 144 - Report of proposed sale of securities
20.2.202416:57EDGAR2Form 144 - Report of proposed sale of securities
20.2.202416:32EDGAR2Form 144 - Report of proposed sale of securities
20.2.202416:22EDGAR2Form 144 - Report of proposed sale of securities
20.2.202416:22EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

NASDAQ
VRTX
Vertex Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten